TBPH
#2562
Theravance Biopharma, Inc. - Ordinary Shares
16.9 2 USD
0.00%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+0.12%
Monthly Change
+3.05%
6 month change
-15.65%
Year Change
+17.91%
Previous Close
16.9 0
Open
16.9 2
Low
16.9 2
High
16.9 2
Volume
77
Financials
- Market Capitalization 872.28 M
- Employee 90
- Founded 2013
- CEO N/A
- Website www.theravance.com
- Headquarter California, United States
- FIGI N/A
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
7.38
Price to sales ratio
7.59
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2551 |  GERN Geron Corporation - Common Stock | 1.38 USD | -2.82% | -6.76% | +20.00% | +7.81% | 885.30 M USD | ||
| 2554 |  PHAT Phathom Pharmaceuticals, Inc. - Common Stock | 11.04 USD | +1.10% | -3.83% | +3.08% | +27.63% | 880.51 M USD | ||
| 2571 |  DSGN Design Therapeutics, Inc. - Common Stock | 13.67 USD | -1.37% | -6.88% | +22.71% | +230.19% | 853.79 M USD | ||
| 2573 |  IVA Inventiva S.A. - American Depository Shares | 4.40 USD | +2.33% | +3.04% | +17.96% | +33.74% | 850.24 M USD |
Frequently asked questions about Theravance Biopharma, Inc. - Ordinary Shares
What is the Theravance Biopharma, Inc. - Ordinary Shares stock price today?
The current price of Theravance Biopharma, Inc. - Ordinary Shares (TBPH) is 16.92. Over the past 24 hours, the stock has changed by +0.12%. Follow the TBPH chart for real-time price dynamics.
What is the stock ticker of Theravance Biopharma, Inc. - Ordinary Shares?
Theravance Biopharma, Inc. - Ordinary Shares trades under the ticker TBPH. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Theravance Biopharma, Inc. - Ordinary Shares stock going up?
TBPH has changed by -0.53% over the last week, +3.05% over the last month, and +17.91% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Theravance Biopharma, Inc. - Ordinary Shares net income for the last quarter?
Theravance Biopharma, Inc. - Ordinary Shares reported net income of -4.93 M for the last quarter. The previous quarter showed 61.02 M, which means net income changed by -108.08%.
How many employees does Theravance Biopharma, Inc. - Ordinary Shares have?
As of the latest available data, Theravance Biopharma, Inc. - Ordinary Shares has 90 employees. Workforce size can provide additional context about the company's scale and operations.
What is Theravance Biopharma, Inc. - Ordinary Shares EBITDA?
Theravance Biopharma, Inc. - Ordinary Shares EBITDA is -9.1 M, and its EBITDA margin is -51.43%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Theravance Biopharma, Inc. - Ordinary Shares stock?
You can buy Theravance Biopharma, Inc. - Ordinary Shares (TBPH) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Theravance Biopharma, Inc. - Ordinary Shares stock?
Investing in Theravance Biopharma, Inc. - Ordinary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TBPH chart and related analysis on metatrader.com as part of your research.